+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Lab-on-a-Chip and Microarrays (Biochip) Market - Growth, Trends, and Forecasts (2020 - 2025)

  • PDF Icon


  • 72 Pages
  • August 2020
  • Region: Europe
  • Mordor Intelligence
  • ID: 5175686
Europe Lab-on-a-Chip and Microarrays (Biochip) Market are expected to witness a high CAGR growth during the forecast period, owing to the rising burden of chronic diseases, increasing applications of proteomics and genomics, and increasing demand for point of care testing. According to the Cancer Atlas, in 2018, approximately 3.9 million new cases of cancer and almost 1.9 million deaths were registered in Europe. Protein microarrays are one of the advancing tools which hold a promising future in cancer proteomics research. Therefore, these factors are expected to fuel market growth in the forecast period.

Key Market Trends

Microarrays are Expected to Exhibit a Significant Growth During the Forecast Period.

Microarrays are expected to show significant growth in the market during the forecast period, owing to the growing burden of morbidity and mortality due to chronic diseases and novel technologies developing in the market.

According to the European Cardiovascular Disease Statistics, 2017, around 45% of all the death is caused due to cardiovascular diseases and almost 37% of deaths in the European Union are due to cardiovascular diseases. Microarrays are capable of profiling lncRNA and mRNA expression in atherosclerotic plaques.

Furthermore, in 2019, Quotient Limited received an approval (CE Mark) for Immunohematology (IH) Microarray for use with its MosaiQ diagnostic platform. Therefore, the aforementioned factors are expected to boost the demand for microarrays in the market over the forecast period.

Competitive Landscape

Some of the key players in the Europe Lab-on-a-Chip and Microarrays (Biochip) Market are Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, GE Healthcare, ThermoFisher Scientific, F. Hoffmann-La Roche Ltd, BioMérieux and Illumina Inc.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1.1 Study Assumptions
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Burden of Chronic Diseases due to Lifestyle Changes
4.2.2 Increasing Demand for Point-of-Care-Testing
4.2.3 Increasing Applications of Proteomics and Genomics in Cancer Research
4.3 Market Restraints
4.3.1 Design Constraints of Lab-on-chip Technology
4.3.2 Availability of Alternative Technologies
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Type
5.1.1 Lab-on-a-Chip
5.1.2 Microarray
5.2 By Products
5.2.1 Instruments
5.2.2 Reagents & Consumables
5.2.3 Software and Services
5.3 By Application
5.3.1 Clinical Diagnostics
5.3.2 Drugs Discovery
5.3.3 Genomics and Proteomics
5.3.4 Others
5.4 By End-User
5.4.1 Biotechnology & Pharmaceutical Companies
5.4.2 Hospitals & Diagnostics Centres
5.4.3 Academic & Research Institute
5.5 By Country
5.5.1 Germany
5.5.2 United Kingdom
5.5.3 France
5.5.4 Italy
5.5.5 Spain
5.5.6 Rest of Europe
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Agilent Technologies
6.1.3 Bio-Rad Laboratories
6.1.4 Perkin Elmer Inc.
6.1.5 GE Healthcare
6.1.6 ThermoFisher Scientific
6.1.7 F. Hoffmann-La Roche Ltd
6.1.8 BioMerieux
6.1.9 Illumina Inc.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Perkin Elmer Inc.
  • GE Healthcare
  • ThermoFisher Scientific
  • F. Hoffmann-La Roche Ltd
  • BioMerieux
  • Illumina Inc.